Synthesis of model morpholine derivatives with biological activities by laccase-catalysed reactions

Biotechnology and Applied Biochemistry

Volumn 54, Issue 4, 2009, Pages 187-195

  Hahn, Veronika ^a   Mikolasch, Annett ^a   Wende, Kristian ^a   Bartrow, Hannelore ^a   Lindequist, Ulrike ^a   Schauer, Frieder ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Amination; Antimicrobial; Biotransformation; Cytostatic; Laccase; Quinone

Indexed keywords

AGAR DISCS; ANTI-FUNGAL; ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY; ANTIMICROBIAL; AROMATIC SYSTEM; ATMOSPHERIC OXYGEN; BACTERIAL STRAINS; BIOACTIVE COMPOUNDS; BIOLOGICAL ACTIVITIES; CANDIDA; CANDIDA ALBICANS; CYTOTOXIC ACTIVITIES; GROWTH INHIBITION; LACCASES; MINIMAL INHIBITORY CONCENTRATION; MORPHOLINES; MYCELIOPHTHORA THERMOPHILA; OXIDOREDUCTASES; PRIMARY AMINO GROUPS; SECONDARY AMINO GROUP; SUBSTITUTED AROMATIC; URINARY BLADDER;

AMINES; AROMATIC COMPOUNDS; CATALYSIS; CELL CULTURE; ENZYMES; FLUORINE CONTAINING POLYMERS; GROUP TECHNOLOGY; MODEL STRUCTURES; OXYGEN;

AMINATION;

1,4 DIHYDROXYNAPHTHALINE; 2 HYDROXY 5 MORPHOLIN 4 YL 3,6 DIOXOCYCLOHEXA 1,4 DIENECARBOXYLIC ACID (2 HYDROXYETHYL)AMIDE; 2 METHYL 5 MORPHOLIN 4 YL[1,4]BENZOQUINONE; 2 METHYL 6 MORPHOLIN 4 YL[1,4]BENZOQUINONE; 2 MORPHOLIN 4 YL[1,4]NAPHTHOQUINONE; 2,3 DIMETHYL 1,4 HYDROQUINONE; 2,3 DIMETHYL 5 MORPHOLIN 4 YL[1,4]BENZOQUINONE; 2,5 BIS (4 MORPHOLIN 4 YL PHENYLAMINO) 3,6 DIOXOCYCLOHEXA 1,4 DIENECARBOXYLIC ACID ETHYL ESTER; 2,5 BIS (4 MORPHOLIN 4 YL PHENYLAMINO) 3,6 DIOXOCYCLOHEXA 1,4 DIENECARBOXYLIC ACID METHYL ESTER; 2,5 DIHYDROXY N (2 HYDROETHYL)BENZAMIDE; 2,5 DIHYDROXYBENZOIC ACID ETHYL ESTER; 2,5 DIHYDROXYBENZOIC ACID METHYL ESTER; 4 MORPHOLINOANILINE; AMPHOTERICIN B; AMPICILLIN; ETOPOSIDE; FENPROPIMORPH; FLUCONAZOLE; GENTAMICIN; LACCASE; METHYL 1,4 HYDROQUINONE; MORPHOLINE; MORPHOLINE DERIVATIVE; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC BIOSYNTHESIS; ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CANCER CELL DESTRUCTION; CANDIDA ALBICANS; CANDIDA MALTOSA; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; DISK DIFFUSION; DRUG STRUCTURE; ENZYME MECHANISM; ESCHERICHIA COLI; FUNGUS; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYDROXYLATION; MINIMUM INHIBITORY CONCENTRATION; MYCELIOPHTHORA THERMOPHILA; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; ASCOMYCOTA; BACTERIA; CANDIDA; CATALYSIS; CELL LINE, TUMOR; CELL SURVIVAL; FUNGAL PROTEINS; HUMANS; LACCASE; MOLECULAR STRUCTURE; MORPHOLINES;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS; CANDIDA MALTOSA; CORYNASCUS HETEROTHALLICUS; POSIBACTERIA;

EID: 70549092139     PISSN: 08854513     EISSN: None     Source Type: Journal    
DOI: 10.1042/BA20090219     Document Type: Article

References (27)

1. Luly, J. R. and Rapoport, H. (1983) J. Am. Chem. Soc. 105, 2859-2866
2. Behforouz, M., Cai, W., Mohammadi, F., Stocksdale, M. G., Gu, Z., Ahmadian, M., Baty, D. E., Etling, M. R., Al-Anzi, C. H., Swiftney, T. M. et al. (2007) Bioorg. Med. Chem. 15, 495-510
3. Grüschow, S., Chang, L.-C., Mao, Y. and Sherman, D. H. (2007) J. Am. Chem. Soc. 129, 6470-6476
4. Moellering, R. C. (2003) Ann. Intern. Med. 138, 135-142
5. Flagothier, C., Piérard-Franchimont, C. and Piérard, G. E. (2005) Mycoses 48, 91-94
6. Niedermeyer, T. H. J., Mikolasch, A. and Lalk, M. (2005) J. Org. Chem. 70, 2002-2008
7. Manda, K., Hammer, E., Mikolasch, A., Niedermeyer, T., Dec, J., Jones, A. D., Benesi, A. J., Schauer, F. and Bollag, J. M. (2005) J. Mol. Catal. B: Enzym. 35, 86-92
8. Agematu, H., Tsuchida, T., Kominato, K., Shibamoto, N., Yoshioka, T., Nishida, H., Okamoto, R., Shin, T. and Murao, S. (1993) J. Antibiot. 46, 141-148
9. Mikolasch, A., Niedermeyer, T. H. J., Lalk, M., Witt, S., Seefeldt, S., Hammer, E., Schauer, F., Gesell, M., Hessel, S., Jülich, W.-D. and Lindequist, U. (2006) Chem. Pharm. Bull. 54, 632-638
10. Agematu, H., Kominato, K., Shibamoto, N., Yoshioka, T., Nishida, H., Okamoto, R., Shin, T. and Murao, S. (1993) Biosci. Biotechnol. Biochem. 8, 1387-1388
11. Mikolasch, A., Niedermeyer, T. H. J., Lalk, M., Witt, S., Seefeldt, S., Hammer, E., Schauer, F., Salazar, M., Hessel, S., Jülich, W.-D. and Lindequist, U. (2007) Chem. Pharm. Bull. 55, 412-416
12. Manda, K., Hammer, E., Mikolasch, A., Gördes, D., Thurow, K. and Schauer, F. (2006) Amino Acids 31, 409-419
13. Hahn, V., Mikolasch, A., Manda, K., Gördes, D., Thurow, K. and Schauer, F. (2009) Amino Acids 37, 315-321
14. Rodríguez-Tudela, J. L., Barchiesi, F., Bille, J., Chryssanthou, E., Cuenca-Estrella, M., Denning, D., Donnelly, J. P., Dupont, B., Fegeler, W., Moore, C. et al. (2003) Clin. Microbiol. Infect. 9, i-viii
15. Feng, B. B., Voehler, M., Zhou, L., Passarelli, M., Harris, C. M., Harris, T. M. and Stone, M. P. (1996) Biochemistry 35, 7316-7329
16. Berka, R. M., Schneider, P., Golightly, E. J., Brown, S. H., Madden, M., Brown, K. M., Halkier, T., Mondorf, K. and Xu, F. (1997) Appl. Environ. Microbiol. 63, 3151-3157
17. Bourbonnais, R. and Paice, M. G. (1990) FEBS Lett. 267, 99-102
18. Jonas, U., Hammer, E., Schauer, F. and Bollag, J. M. (1998) Biodegradation 8, 321-328
19. European Pharmacopoeia (1997) Mikrobiologische Wertbestimmung von Antibiotika, Diffusionsmethode, Edition 6, Deutscher-Apotheker-Verlag, Stuttgart, section 2.7.2.
20. Comment to the European Pharmacopeia (2008) Mikrobiologische Wertbestimmung von Antibiotika, Diffusionsmethode, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, section 2.7.2.
21. Hahn, V., Mikolasch, A., Manda, K., Gördes, D., Thurow, K. and Schauer, F. (2009) J. Mol. Catal. B: Enzym. 60, 76-81
22. Mikolasch, A., Matthies, A., Lalk, M. and Schauer, F. (2008) Appl. Microbiol. Biotechnol. 80, 389-397
23. Manda, K., Gördes, D., Mikolasch, A., Hammer, E., Schmidt, E., Thurow, K. and Schauer, F. (2007) Appl. Microbiol. Biotechnol. 76, 407-416
24. Bolzán, A. D. and Bianchi, M. S. (2001) Mutat. Res. 488, 25-37
25. Bringmann, G., Reichert, M. and Hemberger, Y. (2008) Tetrahedron 64, 515-521
26. Takada, T., Kosugi, Y. and Akiba, M. (1977) Chem. Pharm. Bull. 25, 259-264
27. Bradner, W. T. (2001) Cancer Treat. Rev. 27, 35-50